Table 3 Reported case reports of the patients with primary hepatic MALT lymphoma treated by laparotomy
Case (year) | Age | Sex | Number | Size (cm)* | Preoperative diagnosis | Liver biopsy before surgery | Postoperative adjuvant therapy | Outcome |
|---|---|---|---|---|---|---|---|---|
Isaacson (1995) | 66 | Male | Solitary | 7.5 | Low-grade lymphoma | + | NED, 1 year | |
73 | Female | Solitary | 3.0 | (incidental) | − | N.D | ||
Ueda (1996) | 48 | Male | Solitary | 4.5 | MALT lymphoma | + | Chemotherapy | NED, 3 years |
Maes (1997) | 47 | Female | Solitary | 4 | Low-grade B-cell lymphoma | + | Radiotherapy | NED, 2.5 years |
64 | Male | Solitary | 2 | Liver metastasis from colon cancer | − | N.D | ||
Prabhu (1998) | 62 | Female | Solitary | 6.0 | Small lymphocytes | + | N.D | |
Chen (2000) | 64 | Female | Solitary | N.D | N.D | − | REC, 8 years | |
Mizuno (2002) | 59 | Male | Solitary | 1.5 | HCC | − | NED, 2.5 years | |
Murakami (2002) | 61 | Male | Solitary | 3.4 | Low-grade B-cell lymphoma | + | NED, 1.5 years | |
Yago (2002) | 73 | Male | Solitary | 4 | Non-Hodgkin lymphoma | + | NED, 34 months | |
Takeshima (2004) | 65 | Female | Multiple | 2 | Chronic hepatitis with lymphoid follicles | + | NED, 10 months | |
Gockel (2005) | 36 | Male | Solitary | 6 | MALT lymphoma | + | REC, 14 months | |
Doi (2008) | 58 | Male | Solitary | 2.5 | HCC | − | Chemotherapy | NED, 6 months |
Koubaa Mahjoub (2008) | 59 | Male | Solitary | 2 | (incidental) | − | NED, 5 months | |
Yu (2013) | 38 | Male | Multiple | 2.5 | MALT lymphoma | + | Chemotherapy | NED, 15 months |
Zhong (2014) | 53 | Male | Solitary | 4.5 | Malignant | − | Chemotherapy | NED, 40 months |
Chan (2015) | 59 | Male | Solitary | 2.5 | N.D | − | NED, 4 years | |
Nagata (2015) | 74 | Male | Solitary | 1.5 | ICC | − | NED, 2 years | |
Shiozawa (2015) | 60 | Female | Solitary | 1.5 | Malignant | − | N.D | |
Li (2016) | 44 | Female | Solitary | 1.8 | HCC | − | NED, 27 months | |
Betianu (2017) | 47 | Female | Solitary | 8.5 | Benign | − | Chemotherapy | NED, 9 months |
Dong (2017) | 50 | Male | Solitary | 5 | ICC | − | Chemotherapy | NED, 13 months |
Obiorah (2017) | 80 | Female | Solitary | N.D | HCC | − | REC, 1 year | |
Bohlok (2018) | 68 | Male | Solitary | 4.5 | HCC | − | N.D | |
Choi (2020) | 70 | Male | Multiple | 4.8 | HCC | − | NED, 8 months | |
Yasuda (2020) | 54 | Female | Multiple | N.D | HCC or ICC | − | NED, 12 months | |
Liu (2022) | 65 | Male | Solitary | 7 | Lymphoid tissue hyperplasia with dysplasia | + | alive, 20 months |